Cargando…
The need for a personalized approach for prostate cancer management
The stratification of patients for treatment of prostate cancer is based on very general parameters like prostate-specific antigen, Gleason score, and TNM classification. We use these rough parameters for selection of active surveillance, active treatment, and even for the treatment selection in met...
Autores principales: | Sedelaar, JP Michiel, Schalken, Jack A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425856/ https://www.ncbi.nlm.nih.gov/pubmed/25956920 http://dx.doi.org/10.1186/s12916-015-0344-1 |
Ejemplares similares
-
Suppression of prostate tumor cell survival by antisense oligonucleotide-mediated inhibition of AR-V7 mRNA synthesis
por: Luna Velez, Maria V., et al.
Publicado: (2019) -
Personalized Management in Low-Risk Prostate Cancer: The Role of Biomarkers
por: Dijkstra, Siebren, et al.
Publicado: (2012) -
How accurate is our prediction of biopsy outcome? PCA3-based nomograms in personalized diagnosis of prostate cancer
por: Salagierski, Maciej, et al.
Publicado: (2012) -
Prostate Cancer Claims for a Personalized Medicine
por: Lazzeri, Massimo
Publicado: (2015) -
A short-term intervention with selenium affects expression of genes implicated in the epithelial-to-mesenchymal transition in the prostate
por: Kok, Dieuwertje E.G., et al.
Publicado: (2017)